Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lindner

Showing results (691-700 of 708) with videos related to

Pageof 71
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2018
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2022
A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centersAdela Ademaj, Paraskevi D Veltsista, Dietmar Marder, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 23, 2024
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centersSiyer Roohani, Felix Ehret, Marcus Beck, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Nature Genetics|October 4, 2000
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusY Horikawa, N Oda, N J Cox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.
Vaccines|July 27, 2024
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc StudyJulian Stumpf, Torsten Siepmann, Jörg Schwöbel, et al.
Kidney International Reports|June 9, 2025
<i>COL4A5</i>-p.Gly624Asp is the Predominant Variant in Europe Associated With a Mild Alport Syndrome PhenotypeBastian M Krüger, Annika Jens, Anna Neuhaus, et al.
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
American Journal of Human Genetics|August 5, 2008
Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndromeVincent Cantagrel, Jennifer L Silhavy, Stephanie L Bielas, et al.
Pageof 71

Showing results (691-700 of 708) with videos related to

Sort By:
Pageof 71
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2018
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2022
A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centersAdela Ademaj, Paraskevi D Veltsista, Dietmar Marder, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 23, 2024
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centersSiyer Roohani, Felix Ehret, Marcus Beck, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Nature Genetics|October 4, 2000
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitusY Horikawa, N Oda, N J Cox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.
Vaccines|July 27, 2024
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc StudyJulian Stumpf, Torsten Siepmann, Jörg Schwöbel, et al.
Kidney International Reports|June 9, 2025
<i>COL4A5</i>-p.Gly624Asp is the Predominant Variant in Europe Associated With a Mild Alport Syndrome PhenotypeBastian M Krüger, Annika Jens, Anna Neuhaus, et al.
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
American Journal of Human Genetics|August 5, 2008
Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndromeVincent Cantagrel, Jennifer L Silhavy, Stephanie L Bielas, et al.
Pageof 71